๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for High Grade Epithelial Ovarian Cancer

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer NCT05998135Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: Atovaquone, Biopsy, Computed Tomography, Paracentesis Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer NCT07821879n/a1 site๐Ÿ“ Toulouse Institut Claudius Regaud Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer NCT07125391Phase 21 site๐Ÿ“ Hefei Bai-Rong Xia ยท Tests: Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341Phase 249 sites๐Ÿ“ Birmingham๐Ÿ“ Palo Alto๐Ÿ“ San Francisco Corcept Therapeutics ยท Tests: Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy NCT07504588Phase 213 sites๐Ÿ“ Fayetteville๐Ÿ“ Rogers๐Ÿ“ Springdale National Cancer Institute (NCI) ยท Tests: Anti-VEGF Monoclonal Antibody, Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites๐Ÿ“ Amberg๐Ÿ“ Augsburg๐Ÿ“ Bad Homburg AGO Study Group ยท Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage NRG Oncology ยท Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary NCT06883487n/a1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: No intervention Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging NCT06084195NA1 site๐Ÿ“ Montpellier Institut du Cancer de Montpellier - Val d'Aurelle ยท Tests: Blood sample and tissue sample IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Study of NTB-928 in R/R OC NCT07690189Phase 14 sites๐Ÿ“ Birmingham๐Ÿ“ Omaha๐Ÿ“ Lake Success TeneoSeven, Inc. ยท Tests: NTB-928 Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion โ€ฆ ยท Tests: GTAEXS617, SoC A Study of Radspherinยฎ in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery NCT06504147Phase 210 sites๐Ÿ“ Tampa๐Ÿ“ Leuven๐Ÿ“ Roma Oncoinvent Solutions AS ยท Tests: Radspherin Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer NCT05080556Phase 21 site๐Ÿ“ London University College, London ยท Tests: Carboplatin A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites๐Ÿ“ Denver๐Ÿ“ Sarasota๐Ÿ“ Detroit IDEAYA Biosciences ยท Tests: IDE034 Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer NCT07371104Phase 11 site๐Ÿ“ Seoul Daewoong Pharmaceutical Co. LTD. ยท Tests: DWZ2501 (Olaparib 150mg), DWC202510 (Olaparib 150mg) A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy NCT05460000Phase 250 sites๐Ÿ“ Innsbruck๐Ÿ“ Brussels๐Ÿ“ Ghent North Eastern German Society of Gynaecological Oncology ยท Tests: 3 cycles chemotherapy instead of 6 cycles chemotherapy, 6 cycles chemotherapy Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery NCT07050771Phase 21 site๐Ÿ“ Houston The Methodist Hospital Research Institute ยท Tests: Comprehensive multimodal prehabilitation (CMMP) Study Looking at Biomarkers in Ovarian Cancer NCT03419689NA7 sites๐Ÿ“ Barrie๐Ÿ“ Hamilton๐Ÿ“ Kingston University Health Network, Toronto ยท Tests: Tumour tissue collection, Blood sample collection, Ascites Collection, Fluid Collection A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer NCT06710288Phase 22 sites๐Ÿ“ El Segundo๐Ÿ“ Newport Beach ImmunityBio, Inc. ยท Tests: Gemcitabine, N-803, M-CENK Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer NCT06976892Phase 13 sites๐Ÿ“ Cambridge๐Ÿ“ Sutton๐Ÿ“ Cardiff Institute of Cancer Research, United Kingdom ยท Tests: Dose Level 2 (starting dose), Dose Level 1, Dose Level -1, Dose Level 3, Maximum Tolerated Dose Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer NCT06404671NA1 site๐Ÿ“ Alexandria Alexandria University ยท Tests: Delayed interval cytoreductive surgery (DICS), Early interval cytoreductive surgery (EICS) A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach๐Ÿ“ Aurora Volastra Therapeutics, Inc. ยท Tests: VLS-1488 DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics NCT02288676n/a1 site๐Ÿ“ Montreal McGill University Folate Receptor Alpha (FRฮฑ) Expression and Heterogeneity in Epithelial Ovarian Cancer NCT07889843n/a1 site๐Ÿ“ Athens Hellenic Cooperative Oncology Group MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites๐Ÿ“ Graz๐Ÿ“ Graz๐Ÿ“ Innsbruck Swiss GO Trial Group ยท Tests: Letrozole 2.5mg, Placebo A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) NCT07743164Phase 34 sites๐Ÿ“ Fountain Valley๐Ÿ“ Orlando๐Ÿ“ Tel Aviv Merck Sharp & Dohme LLC ยท Tests: R-DXd, Bevacizumab, Carboplatin, Paclitaxel, Gemcitabine Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy NCT06466382NA10 sites๐Ÿ“ Baden๐Ÿ“ Basel๐Ÿ“ Sankt Gallen Swiss GO Trial Group ยท Tests: Treatment recommendation by molecular tumorboard (mTB) based on tumor profiling, Carboplatin / Paclitaxel Chemotherapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy